Safety Study of NHL With 90Y-hLL2 IgG

Clinical trial NCT00421395 · COMPLETED

Trial details

NCT number: NCT00421395
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

NHL B-cell NHL Non-Hodgkins Lymphoma

Start date: 2002-08-01
Primary completion: 2007-10-01
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.